Navigation Links
Ceregene Completes Enrollment of Phase 2 Clinical Trial for Parkinson's Disease
Date:11/14/2007

ts. With positive results from the Phase 2 study, we would expect to initiate a Phase 3 trial for CERE-120 in 2009."

"CERE-120 represents a truly revolutionary future treatment option for Parkinson's disease patients, given that a single treatment is not only intended to improve the symptoms of the disease, but also slow disease progression. We appreciate the courage of the patients and the efforts of the physicians who have participated in our Phase 2 trial and hope that CERE-120 may someday provide a meaningful difference in the lives of Parkinson's disease patients. We thank all trial participants for enrolling this study safely and within the projected time frame," stated Raymond T. Bartus, Ph.D., Ceregene's senior vice president of clinical and preclinical R&D and chief operating officer.

About CERE-120

CERE-120 is composed of an adeno-associated virus (AAV) vector carrying the gene for neurturin (NTN), a naturally occurring protein known to repair damaged and dying dopamine-secreting neurons, keeping them alive and functioning normally. NTN is a member of the same protein family as glial cell-derived neurotrophic factor (GDNF). The two molecules have similar pharmacological properties, and both have been shown to benefit the midbrain dopamine neurons that degenerate in Parkinson's disease and are responsible for the major motor impairments. CERE-120 is delivered by stereotactic injection to the affected area of the brain, providing stable, long-lasting expression of NTN in a highly targeted fashion. Genzyme Corporation (Nasdaq: GENZ) has licensed the ex-North American rights for the development and commercialization of CERE-120 from Ceregene, a deal which was announced in June 2007.

About Parkin
'/>"/>

SOURCE Ceregene, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Eligard(R) six-month formulation successfully completes European approval procedure
2. The ScottCare Corporation Completes Acquisition of Rozinn Electronics, a Leading Manufacturer of Cardiac Diagnostic Products
3. EaglePicher Corporation Completes Transaction to Sell EaglePicher Boron, LLC to Ceradyne, Inc. for $69 Million
4. Symmetry Medical Completes Acquisition Of Specialty Surgical Instruments
5. GSI Securitization Completes Merger and Domicile Transfer
6. Medical Services International Inc. Completes Testing for European Union (EU) Application
7. Inverness Completes Acquisition of Cholestech
8. Billians HealthDATA Completes Comprehensive Long Term Care Database Update
9. Synova Completes Sale of $3.3 Million in Senior Convertible Notes and Warrants
10. Explorer completes the map ... for the bodys blueprint
11. Labopharm completes enrolment for Phase III clinical study for its once-daily trazodone antidepressant drug
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2014)... Parties involved in federally-filed Tylenol lawsuits ( http://www.tylenollawsuitclaims.com/ ) ... September, where issues related to claims involving the pain ... Pennsylvania, Bernstein Liebhard LLP reports. , According to ... website, the meeting is scheduled to take place on ... latest of several Tylenol conferences that have taken place ...
(Date:9/1/2014)... Top10BestSEOHosting.com has recently compared many web hosting companies. ... is here to announce that JustHost, Bluehost and ... 2014. , JustHost ( http://www.justhost.com/track/seohosts ) provides new ... plan. The company’s approach to hosting is to ... and powerful enough for anyone to use. And ...
(Date:9/1/2014)... Daily Gossip reveals in it's review ... that gives members access to thousands of professionally designed ... resource aims to help both people who plan on ... are looking for inspiration in creating one of a ... Now by visiting the official website at: http://www.dailygossip.org/atattoo-me-now-6444 ...
(Date:9/1/2014)... 01, 2014 AttorneyOne.com, a recognized authority ... latest information from the FDA on DePuy Synthes ... announced on August 28, that specific lots of DePuy ... I) as the device may reverse directions after surgery. ... (CMF) Distraction System is an implant used to lengthen ...
(Date:9/1/2014)... Viejo, California (PRWEB) September 01, 2014 Developers ... a new tutorial video for the ProWorld Plugin from Pixel ... Final Cut Pro X can do and users now have ... HDRI images.” Said Christina Austin, CEO of Pixel Film Studios. ... definite game changer.” , Learn how to turn a 2D ...
Breaking Medicine News(10 mins):Health News:Tylenol Lawsuit News: Bernstein Liebhard LLP Notes Upcoming Status Conference in Pennsylvania Litigation 2Health News:Tylenol Lawsuit News: Bernstein Liebhard LLP Notes Upcoming Status Conference in Pennsylvania Litigation 3Health News:Tylenol Lawsuit News: Bernstein Liebhard LLP Notes Upcoming Status Conference in Pennsylvania Litigation 4Health News:Why Top10BestSEOHosting.com Calls Them Great Web Hosting Suppliers 2Health News:Tattoo Me Now Review Reveals Unique Ideas for Tattoo Designs 2Health News:DePuy Synthes Craniomaxillofacial Distraction System Recalled (Class I): AttorneyOne Monitors and Keeps Consumers Informed 2Health News:DePuy Synthes Craniomaxillofacial Distraction System Recalled (Class I): AttorneyOne Monitors and Keeps Consumers Informed 3Health News:Pixel Film Studios Released a New Tutorial Entitled ProWorld Lesson Exclusively for Final Cut Pro X 2
... ANA, Calif., April 2, 2008 Grubb &,Ellis Healthcare ... in Lakeland, Fla., Located at 3035, 3037, 3131, ... complex is comprised of four identical buildings. Each,building has ... square feet. Built in 1996 and 1998 on approximately ...
... a,bipartisan compromise brokered by Foreign Affairs Committee Chairman ... to expand the,landmark U.S. effort to combat HIV/AIDS ... millions of lives., Despite efforts by some ... provides, the Tom Lantos and Henry J. Hyde ...
... 2008 Ventas, Inc.,(NYSE: VTR ) ("Ventas" or ... regarding the Company at the Credit Suisse 2008 Global,Real ... 2008 at 2:50 p.m.,Eastern Time., The presentation will ... at http://www.ventasreit.com . Any written materials,accompanying the presentation ...
... Eye Disease Patients Rising, CHICAGO, April 2 ... eye disease and, according to the latest research,from ... that number,is continuing to climb. With more than ... 30 million suffer from leading causes of vision ...
... Speaker Nancy,Pelosi spoke on the House floor this ... and Malaria Act, which provides,$50 billion over five years ... are the Speaker,s remarks:, "I want to commend ... first,piece of legislation to come out of the Foreign ...
... Life-saving Legislation Is Now Ready for Action on the ... following is a,statement by Bernadette A. Toomey, President and ... the U.S. House of,Representatives Energy and Commerce Committee for ... Act (H.R. 1108). We urge the full,House to quickly ...
Cached Medicine News:Health News:Grubb & Ellis Healthcare REIT Acquires Vista Professional Center in Lakeland, Fla. 2Health News:Grubb & Ellis Healthcare REIT Acquires Vista Professional Center in Lakeland, Fla. 3Health News:Grubb & Ellis Healthcare REIT Acquires Vista Professional Center in Lakeland, Fla. 4Health News:House Overwhelmingly Approves Renewal and Tripling of Successful U.S. Global AIDS Prevention Effort 2Health News:House Overwhelmingly Approves Renewal and Tripling of Successful U.S. Global AIDS Prevention Effort 3Health News:Eye Disease Continuing to Increase Among Americans 2Health News:Eye Disease Continuing to Increase Among Americans 3Health News:Pelosi on Global HIV/AIDS Bill: 'There is a Moral Imperative to Combat This Epidemic' 2Health News:Pelosi on Global HIV/AIDS Bill: 'There is a Moral Imperative to Combat This Epidemic' 3
(Date:8/30/2014)... , Aug. 30, 2014   Royal Philips  ... Affiniti, a new ultrasound system designed to ... demands of increasing patient volumes and cost pressures. Making ... 2014 in Barcelona this ... facing more patients with fewer resources deliver high quality ...
(Date:8/29/2014)... 2014 The clinical and medical insights provided ... between a product,s success or failure. Despite this, many ... targets – and then to coordinate activities and outreach ... upon which successful KOL engagement rests. ... internal inconsistencies in their KOL management systems and are ...
(Date:8/29/2014)... 2014 Pomerantz LLP has filed a class ... (NASDAQ: EDAP ) and certain of its ... Court, Southern District of New York ... a class consisting of all persons or entities who ... 30, 2014, inclusive (the "Class Period"). This class action seeks ...
Breaking Medicine Technology:Philips Debuts New Affiniti Ultrasound System at the European Society of Cardiology Congress 2014 2Philips Debuts New Affiniti Ultrasound System at the European Society of Cardiology Congress 2014 3Philips Debuts New Affiniti Ultrasound System at the European Society of Cardiology Congress 2014 4Implementing a Strategic Thought Leader Management & Engagement System 2SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against EDAP TMS S.A. and Certain Officers - EDAP 2SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against EDAP TMS S.A. and Certain Officers - EDAP 3
... N.Y., Oct. 15 Building on the success of ... response to growing interest from emergency care providers across ... Advanced. , The ALS Simulator is a ... of lifesaving skills in medical emergencies including CPR, ACLS, ...
... Ind., Oct. 15 Press Ganey Associates, Inc. today ... (NYSE: HMA ) to help measure and improve ... company started working with HMA on October 1, 2009. ... acute-care hospitals, with approximately 8,000 licensed beds, in non-urban ...
Cached Medicine Technology:New ALS Patient Simulator Advanced Provides Valuable Training for EMS Teams and In-Hospital Emergency Personnel 2Press Ganey Partners With Health Management Associates 2
Dilator...
Microscopic scissors, curved...
Microscopic needle holder, curved...
... Back discomfort is a complaint ... wear our most comfortable apron. ... weight off the shoulders and ... shoulder pads are standard for ...
Medicine Products: